| |
|
|
|
Celldex Therapeutics Inc.  
|
|
0.2605 0.001 (0%) |
01-15 16:00 |
|
Open: |
0.26 |
Pre close: |
0.2597 |
Target:
|
0.35
|
|
High: |
0.265 |
Low: |
0.249 |
Resistance:
|
0.30
0.35
|
|
Volume: |
931,952 |
Market Cap: |
45M |
Support:
|
0.23
0.18
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.26
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
0.23 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.35  |
Stochastic Oscillator |
%K(14,3):
|
80.17 |
|
MA(250): |
0.94 |
%D(3): |
81.17 |
|
Average Volume(K) |
3-Month: |
177742
|
52-Week |
High:
|
2.90 |
|
10-Days: |
156426 |
Low: |
0.18 |
|
RSI |
RSI(14):
|
52.12 |
Change(%): |
-90.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-84.4 |
Shares Out. (M) |
172.47 |
|
EPS Est. Current Year |
-1.040 |
Return on Assets (ttm) |
-60.1 |
Shares Float (M) |
165.81 |
|
EPS Est. Next Year |
-0.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.280 |
Qtrly Rev. Growth |
-76.0 |
% Held by Institutions |
40.30 |
|
Forward EPS |
-0.818 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.350 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.47 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-79.33 |
P/S |
561605440.00 |
|
Operating Margin |
-781.42 |
Levered Free Cash Flow
(M) |
-49.08 |
P/CF |
-0.57 |
|
|
|
|
|
|
